![]() |
|
|
Vol. 289, Issue 3, 1678-1687, June 1999
Novartis Pharma AG, Nervous System Research, Basel,
Switzerland (F.G., S.L., T.L., W.I., D.L., B.S., R.K., S.U., D.S.,
C.P., M.S., P.J.F.); Istituto Mediterraneo di Neuroscienze
"Neuromed," Pozzilli, Italy (V.B., G.B., F.N.); SIBIA Neurosciences
Incorporated, La Jolla, California (M.A.V., S.D.H., E.C.J.); and
University of Catania, Catania, Italy (F.N.)
Group III metabotropic glutamate receptors (mGluRs) are thought to
modulate neurotoxicity of excitatory amino acids, via mechanisms of
presynaptic inhibition, such as regulation of neurotransmitter release.
Here, we describe
(R,S)-4-phosphonophenylglycine (PPG) as a
novel, potent, and selective agonist for group III mGluRs. In
recombinant cell lines expressing the human receptors hmGluR4a, hmGluR6, hmGluR7b, or hmGluR8a, EC50 values for
(R,S)-PPG of 5.2 ± 0.7 µM,
4.7 ± 0.9 µM, 185 ± 42 µM, and 0.2 ± 0.1 µM,
respectively, were measured. The compound showed EC50 and
IC50 values of
200 µM at group I and II hmGluRs and was
inactive at cloned human N-methyl-D-aspartate,
-amino-3-hydroxy-5-methyl-isoxazole-4-propionate, and kainate
receptors (>300 µM). On the other hand, it showed micromolar
affinity for a Ca2+/Cl
-dependent
L-glutamate binding site in rat brain, similar to other phosphono-substituted amino acids like
L-2-amino-4-phosphonobutyrate. In cultured cortical
neurons, (R,S)-PPG provided protection
against a toxic pulse of
N-methyl-D-aspartate (EC50 = 12 µM), which was reversed by the group III mGluR antagonist
(R,S)-
-methylserine-O-phosphate but not by the group II antagonist
(2S)-
-ethylglutamate. Moreover, (R,S)-PPG protected against
N-methyl-D-aspartate- and quinolinic acid-induced striatal lesions in rats and was anticonvulsive in the
maximal electroshock model in mice. In contrast to the group III mGluR
agonists L-2-amino-4-phosphonobutyrate and
L-serine-O-phosphate, (R,S)-PPG showed no proconvulsive effects
(2200 nmol i.c.v.). These data provide novel in vivo evidence for group
III mGluRs as attractive targets for neuroprotective and anticonvulsive
therapy. Also, (R,S)-PPG represents an
attractive tool to analyze the roles of group III mGluRs in nervous
system physiology and pathology.
This article has been cited by other articles:
![]() |
R. M. Hallock, C. J. Martyniuk, and T. E. Finger Group III Metabotropic Glutamate Receptors (mGluRs) Modulate Transmission of Gustatory Inputs in the Brain Stem J Neurophysiol, July 1, 2009; 102(1): 192 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Zhang, F. Bertaso, V. Eulenburg, M. Lerner-Natoli, G. A. Herin, L. Bauer, J. Bockaert, L. Fagni, H. Betz, and A. Scheschonka Knock-In Mice Lacking the PDZ-Ligand Motif of mGluR7a Show Impaired PKC-Dependent Autoinhibition of Glutamate Release, Spatial Working Memory Deficits, and Increased Susceptibility to Pentylenetetrazol J. Neurosci., August 20, 2008; 28(34): 8604 - 8614. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhang and G. J. Marek Group III Metabotropic Glutamate Receptor Agonists Selectively Suppress Excitatory Synaptic Currents in the Rat Prefrontal Cortex Induced by 5-Hydroxytryptamine2A Receptor Activation J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 437 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Lieske and J.-M. Ramirez Pattern-Specific Synaptic Mechanisms in a Multifunctional Network. II. Intrinsic Modulation by Metabotropic Glutamate Receptors J Neurophysiol, March 1, 2006; 95(3): 1334 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mitsukawa, R. Yamamoto, S. Ofner, J. Nozulak, O. Pescott, S. Lukic, N. Stoehr, C. Mombereau, R. Kuhn, K. H. McAllister, et al. From The Cover: A selective metabotropic glutamate receptor 7 agonist: Activation of receptor signaling via an allosteric site modulates stress parameters in vivo PNAS, December 20, 2005; 102(51): 18712 - 18717. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bough, D. D. Mott, and R. J. Dingledine Medial Perforant Path Inhibition Mediated by mGluR7 Is Reduced After Status Epilepticus J Neurophysiol, September 1, 2004; 92(3): 1549 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Iacovelli, L. Capobianco, M. Iula, V. Di Giorgi Gerevini, A. Picascia, J. Blahos, D. Melchiorri, F. Nicoletti, and A. De Blasi Regulation of mGlu4 Metabotropic Glutamate Receptor Signaling by Type-2 G-Protein Coupled Receptor Kinase (GRK2) Mol. Pharmacol., May 1, 2004; 65(5): 1103 - 1110. [Abstract] [Full Text] |
||||
![]() |
N. Pedersen, S. Mortensen, S. B. Sorensen, M. W. Pedersen, K. Rieneck, L. F. Bovin, and H. S. Poulsen Transcriptional Gene Expression Profiling of Small Cell Lung Cancer Cells Cancer Res., April 15, 2003; 63(8): 1943 - 1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Taylor, L. T. Diemel, and J. M. Pocock Activation of Microglial Group III Metabotropic Glutamate Receptors Protects Neurons against Microglial Neurotoxicity J. Neurosci., March 15, 2003; 23(6): 2150 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Lee, R. K. S. Wong, S.-C. Chuang, H.-S. Shin, and R. Bianchi Role of Synaptic Metabotropic Glutamate Receptors in Epileptiform Discharges in Hippocampal Slices J Neurophysiol, October 1, 2002; 88(4): 1625 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Tong, R. Ouedraogo, and A. L. Kirchgessner Localization and function of group III metabotropic glutamate receptors in rat pancreatic islets Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1324 - E1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Collard, K. A. Park, M. C. Montalto, S. Alapati, J. A. Buras, G. L. Stahl, and S. P. Colgan Neutrophil-derived Glutamate Regulates Vascular Endothelial Barrier Function J. Biol. Chem., April 19, 2002; 277(17): 14801 - 14811. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. W. Preuss, G. Koller, M. Bahlmann, P. Zill, M. Soyka, and B. Bondy NO ASSOCIATION BETWEEN METABOTROPIC GLUTAMATE RECEPTORS 7 AND 8 (MGLUR7 AND MGLUR8) GENE POLYMORPHISMS AND WITHDRAWAL SEIZURES AND DELIRIUM TREMENS IN ALCOHOL-DEPENDENT INDIVIDUALS Alcohol Alcohol., March 1, 2002; 37(2): 174 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sansig, T. J. Bushell, V. R. J. Clarke, A. Rozov, N. Burnashev, C. Portet, F. Gasparini, M. Schmutz, K. Klebs, R. Shigemoto, et al. Increased Seizure Susceptibility in Mice Lacking Metabotropic Glutamate Receptor 7 J. Neurosci., November 15, 2001; 21(22): 8734 - 8745. [Abstract] [Full Text] [PDF] |
||||